Status:

COMPLETED

Open-Label C1 Esterase Inhibitor (C1INH-nf) for the Treatment of Acute Hereditary Angioedema (HAE) Attacks

Lead Sponsor:

Shire

Conditions:

Hereditary Angioedema

Eligibility:

All Genders

1+ years

Phase:

PHASE3

Brief Summary

The study objective was to evaluate the safety and efficacy of repeat use of C1INH-nf for the treatment of acute HAE attacks.

Detailed Description

A total of 113 subjects were enrolled in the study. One-hundred-one (101) subjects received C1INH-nf for the treatment of 1 or more HAE attacks and were analyzed for efficacy. The study design also al...

Eligibility Criteria

Inclusion

  • This study was open to all subjects who:
  • Completed participation in LEVP2005-1/A (NCT00289211) and were not participating in LEVP2005-1/B (NCT01005888), any time after the 3-day telephone follow-up
  • Completed participation in LEVP2005-1/B any time after the final prophylactic therapy in Part B
  • Were enrolled but not randomized in LEVP2005-1/A after Part A was closed
  • Were excluded from LEVP2005-1 for any of the following reasons:
  • Pregnancy or lactation
  • Age less than 6 years
  • Narcotic addiction
  • Presence of anti-C1INH autoantibodies
  • Were not enrolled in LEVP2005-1 after enrollment in LEVP2005-1 was closed, under the following circumstances:
  • Had a diagnosis of HAE: evidence of a low C4 level plus either a low C1INH antigenic level or a low C1INH functional level, or
  • Had a known HAE-causing C1INH mutation, or
  • Had a diagnosis of HAE based on a strong family history of HAE as determined by the principal investigator

Exclusion

  • History of allergic reaction to C1INH or other blood products
  • Participated in any other investigational drug study within the past 30 days
  • Received blood or a blood product in the past 60 days other than C1INH-nf

Key Trial Info

Start Date :

September 21 2006

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

March 31 2009

Estimated Enrollment :

113 Patients enrolled

Trial Details

Trial ID

NCT00438815

Start Date

September 21 2006

End Date

March 31 2009

Last Update

June 8 2021

Active Locations (30)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 8 (30 locations)

1

Allergy and Immunology Associates

Scottsdale, Arizona, United States, 85251

2

Allergy and Asthma Clinic of Northwest Arkansas

Bentonville, Arkansas, United States, 72712

3

UCLA-David Geffen School of Medicine

Los Angeles, California, United States, 90095

4

University of California, San Diego

San Diego, California, United States, 92093-0732